David Klonoff, M.D., FACP, FRCP, Fellow AIMBE
Medical Advisory Board Member
Dr. Klonoff is an endocrinologist with extensive clinical experience in glucose monitoring technology. Dr. Klonoff serves as a medical director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF. He has over 280 publications. Dr. Klonoff has been a Principal Investigator on over 110 clinical trials of diabetes drugs and devices and has been lead investigator on multicenter trials for Novo, Sanofi, Medtronic, Biorad, and Diasome.
In 2012, Dr. Klonoff was cited by American Institute of Medical and Biological Engineering as as among the top 2% of the world’s bioengineers for his engineering work in diabetes technology. Dr. Klonoff was invited to speak to the US Congressional Diabetes Caucus in 2017, participate in the White House Health and Cybersecurity Roundtable in 2015, and speak at the European Parliament in 2010. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology.